Dave Muoio

First announced by President Trump on Friday as a nationwide resource, the testing-referral service already seems to have reached its capacity among California's Santa Clara and San Mateo counties.

The iRhythm Technologies founder's new startup will use these funds to wrap up clinical testing of its device, and push toward a commercial launch.

Also: Consumer survey suggests declining digital health engagement; Iran's COVID-19 app pulled from Play Store after malware accusations.

The funds will help the New York City-based platform extend its growth and deliver new product offerings.

Livongo Health, Hinge Health, Hello Heart, Torchlight and Whil each underwent "rigorous clinical, data security and business evaluation" for inclusion in the program.

IVP led the round, which adds to the company's existing $100 million in equity investments.

Both features have already been announced or implemented by some of the company's smartwatch competition.

The new functionalities will be available to provider teams using both the smartphone and desktop versions of the Microsoft 365 platform.

CMS-regulated payers will begin supporting HL7 FHIR APIs next year, allowing third-party developers to include claims data and other patient health information in their apps.

The funds will support expansion into new markets, as well as product launches and general scaling of its business.